 Connection
Joseph Saseen to Hypertension
This is a "connection" page, showing publications Joseph Saseen has written about Hypertension.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
2.864 |
|
|
|
-
MacLaughlin EJ, Saseen JJ. It's About Blood Pressure Reduction and Control. Am J Hypertens. 2024 05 15; 37(6):396-398.
Score: 0.471
-
Saseen JJ, Ghushchyan V, Nair KV. Comparing clinical effectiveness and drug toxicity with hydrochlorothiazide and chlorthalidone using two potency ratios in a managed care population. J Clin Hypertens (Greenwich). 2015 Feb; 17(2):134-40.
Score: 0.245
-
Wilson L, Nair KV, Saseen JJ. Comparison of new-onset gout in adults prescribed chlorthalidone vs. hydrochlorothiazide for hypertension. J Clin Hypertens (Greenwich). 2014 Dec; 16(12):864-8.
Score: 0.242
-
Ripley TL, Saseen JJ. ?-blockers: a review of their pharmacological and physiological diversity in hypertension. Ann Pharmacother. 2014 Jun; 48(6):723-33.
Score: 0.234
-
Saseen JJ, Ghushchyan V, Kaila S, Allen RR, Nair KV. Maintaining goal blood pressures after switching from olmesartan to other angiotensin receptor blockers. J Clin Hypertens (Greenwich). 2013 Dec; 15(12):888-92.
Score: 0.225
-
Sontheimer D, Hitchcock K, Saseen J. Clinical inquiries. Are there big differences among beta-blockers in treating essential hypertension? J Fam Pract. 2007 Apr; 56(4):312-4.
Score: 0.144
-
Lochner J, Rugge B, Judkins D, Saseen J. Clinical inquiries. How effective are lifestyle changes for controlling hypertension? J Fam Pract. 2006 Jan; 55(1):73-4.
Score: 0.132
-
Fisher M, Blackwell J, Saseen J. Clinical inquiries. What is the best way to identify patients with white-coat hypertension? J Fam Pract. 2005 Jun; 54(6):549-50, 552.
Score: 0.127
-
Saseen JJ, Turner C, Russell RG. Clinical inquiries. What is the best regimen for newly diagnosed hypertension? J Fam Pract. 2005 Mar; 54(3):281-2.
Score: 0.124
-
Saseen JJ, MacLaughlin EJ, Westfall JM. Treatment of uncomplicated hypertension: are ACE inhibitors and calcium channel blockers as effective as diuretics and beta-blockers? J Am Board Fam Pract. 2003 Mar-Apr; 16(2):156-64.
Score: 0.108
-
Zheutlin AR, Derington CG, King JB, Berchie RO, Herrick JS, Dixon DL, Cohen JB, Shimbo D, Kronish IM, Saseen JJ, Muntner P, Moran AE, Bress AP. Factors associated with antihypertensive monotherapy among US adults with treated hypertension and uncontrolled blood pressure overall and by race/ethnicity, National Health and Nutrition Examination Survey 2013-2018. Am Heart J. 2022 06; 248:150-159.
Score: 0.099
-
Derington CG, King JB, Herrick JS, Shimbo D, Kronish IM, Saseen JJ, Muntner P, Moran AE, Bress AP. Trends in Antihypertensive Medication Monotherapy and Combination Use Among US Adults, National Health and Nutrition Examination Survey 2005-2016. Hypertension. 2020 04; 75(4):973-981.
Score: 0.088
-
Billups SJ, Saseen JJ, Vande Griend JP, Schilling LM. Blood pressure control rates measured in specialty vs primary care practices within a large integrated health system. J Clin Hypertens (Greenwich). 2018 09; 20(9):1253-1259.
Score: 0.079
-
Saseen JJ, Porter JA, Barnette DJ, Bauman JL, Zajac EJ, Carter BL. Postabsorption concentration peaks with brand-name and generic verapamil: a double-blind, crossover study in elderly hypertensive patients. J Clin Pharmacol. 1997 Jun; 37(6):526-34.
Score: 0.073
-
Kelly MS, Saseen JJ, Marrs JC. Assessment of achieved systolic blood pressure in newly treated hypertensive patients aged 60-79 years before and after Eighth Joint National Committee recommendations. Ther Adv Cardiovasc Dis. 2017 Feb; 11(2):63-71.
Score: 0.071
-
Saseen JJ, Carter BL, Brown TE, Elliott WJ, Black HR. Comparison of nifedipine alone and with diltiazem or verapamil in hypertension. Hypertension. 1996 Jul; 28(1):109-14.
Score: 0.068
-
Saseen JJ, Carter BL. Dual calcium-channel blocker therapy in the treatment of hypertension. Ann Pharmacother. 1996 Jul-Aug; 30(7-8):802-10.
Score: 0.068
-
Fixen CW, Saseen JJ, Vande Griend JP, Linnebur SA. Assessment of blood pressure in patients with hypertension aged 60-79 years before and after the publication of the 2014 Eighth Joint National Committee report. Ther Adv Cardiovasc Dis. 2016 Apr; 10(2):67-73.
Score: 0.066
-
Tuchscherer RM, Nair K, Ghushchyan V, Saseen JJ. Simvastatin prescribing patterns before and after FDA dosing restrictions: a retrospective analysis of a large healthcare claims database. Am J Cardiovasc Drugs. 2015 Feb; 15(1):27-34.
Score: 0.062
-
Thompson LA, Saseen JJ, O'Bryant CL, Allen RR, Nair KV. Claims analysis of hypertension occurrence, severity changes and patterns of antihypertensive use in cancer patients receiving vascular endothelial growth factor inhibitors. J Oncol Pharm Pract. 2015 Aug; 21(4):258-67.
Score: 0.059
-
Hanselin MR, Saseen JJ, Allen RR, Marrs JC, Nair KV. Description of antihypertensive use in patients with resistant hypertension prescribed four or more agents. Hypertension. 2011 Dec; 58(6):1008-13.
Score: 0.049
-
Mehos BM, Saseen JJ, MacLaughlin EJ. Effect of pharmacist intervention and initiation of home blood pressure monitoring in patients with uncontrolled hypertension. Pharmacotherapy. 2000 Nov; 20(11):1384-9.
Score: 0.023
-
Joy MS, DeHart RM, Gilmartin C, Hachey DM, Hudson JQ, Pruchnicki M, Dumo P, Grabe DW, Saseen J, Zillich AJ. Clinical pharmacists as multidisciplinary health care providers in the management of CKD: a joint opinion by the Nephrology and Ambulatory Care Practice and Research Networks of the American College of Clinical Pharmacy. Am J Kidney Dis. 2005 Jun; 45(6):1105-18.
Score: 0.008
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|